LATOYA BRAGG: Open Payments
NPI 1033752951 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 68 payments from 14 companies in 2025. Trend: 2023 $2,946 · 2024 $2,422 · 2025 $2,399
Food & beverage: $1,631Travel & lodging: $767
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 6 | $1,171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $246 |
| Axsome Therapeutics, Inc. | 7 | $231 |
| ABBVIE INC. | 19 | $198 |
| Supernus Pharmaceuticals, Inc. | 7 | $164 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 1 | $88 |
| Lundbeck LLC | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, Auvelity, VRAYLAR, Qelbree, REXULTI, SPRAVATO, FANAPT.
Industry payments across VA — which companies pay providers there.
